Skip to main content
. 2018 Dec 20;34(2):365–373. doi: 10.1093/humrep/dey364

Table IV.

Associations of early pregnancy bisphenol and phthalate urine concentrations with gestational hypertensive disorders.

Gestational hypertension, OR (95% CI) (n = 40) Pre-eclampsia, OR (95% CI) (n = 24)
Basic model Adjusted model Basic model Adjusted model
Total bisphenols 1.05 (0.81, 1.36) 1.03 (0.78, 1.35) 1.20 (0.87, 1.66) 1.14 (0.81, 1.61)
Bisphenol A 1.03 (0.83, 1.27) 1.02 (0.82, 1.26) 1.22 (0.94, 1.59) 1.16 (0.88, 1.53)
Bisphenol S 1.04 (0.86, 1.34) 1.03 (0.85, 1.26) 1.05 (0.83, 1.34) 1.02 (0.80, 1.31)
Phthalic acid 1.05 (0.78, 1.41) 0.97 (0.71, 1.31) 1.30 (0.90, 1.86) 1.19 (0.81, 1.73)
LMW phthalate metabolites 1.12 (0.89, 1.42) 1.10 (0.86, 1.40) 1.01 (0.75, 1.36) 0.95 (0.70, 1.30)
HMW phthalate metabolites 1.03 (0.74, 1.43) 1.02 (0.72, 1.44) 1.00 (0.66, 1.52) 0.92 (0.60, 1.42)
DEHP metabolites 1.03 (0.75, 1.42) 1.03 (0.74, 1.44) 1.05 (0.70, 1.57) 0.98 (0.65, 1.49)
DNOP metabolites 0.95 (0.70, 1.30) 0.98 (0.70, 1.38) 1.13 (0.76, 1.69) 1.07 (0.71, 1.62)

N = 1219. Values are based on basic and multivariable multinomial regression models that reflect OR and 95% CI for gestational hypertensive disorders per log unit increase in urinary Total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations.

Basic models are adjusted for creatinine. Adjusted models are adjusted for maternal age, maternal pre-pregnancy BMI, parity, ethnicity, education, maternal smoking, maternal alcohol, folic acid supplementation and creatinine.